IL120521A0 - Use of bradykinin antagonists for the production of pharmaceuticals for the treatment of chronic fibrogenetic liver disorders and acute liver disorders - Google Patents

Use of bradykinin antagonists for the production of pharmaceuticals for the treatment of chronic fibrogenetic liver disorders and acute liver disorders

Info

Publication number
IL120521A0
IL120521A0 IL12052197A IL12052197A IL120521A0 IL 120521 A0 IL120521 A0 IL 120521A0 IL 12052197 A IL12052197 A IL 12052197A IL 12052197 A IL12052197 A IL 12052197A IL 120521 A0 IL120521 A0 IL 120521A0
Authority
IL
Israel
Prior art keywords
liver disorders
pharmaceuticals
treatment
production
bradykinin antagonists
Prior art date
Application number
IL12052197A
Other languages
English (en)
Original Assignee
Hoechst Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst Ag filed Critical Hoechst Ag
Publication of IL120521A0 publication Critical patent/IL120521A0/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/043—Kallidins; Bradykinins; Related peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Endocrinology (AREA)
  • Zoology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
IL12052197A 1996-03-27 1997-03-25 Use of bradykinin antagonists for the production of pharmaceuticals for the treatment of chronic fibrogenetic liver disorders and acute liver disorders IL120521A0 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19612067A DE19612067A1 (de) 1996-03-27 1996-03-27 Verwendung von Bradykinin-Antagonisten zur Herstellung von Arzneimitteln zur Behandlung von chronisch fibrogenetischen Lebererkrankungen und akuten Lebererkrankungen

Publications (1)

Publication Number Publication Date
IL120521A0 true IL120521A0 (en) 1997-07-13

Family

ID=7789557

Family Applications (1)

Application Number Title Priority Date Filing Date
IL12052197A IL120521A0 (en) 1996-03-27 1997-03-25 Use of bradykinin antagonists for the production of pharmaceuticals for the treatment of chronic fibrogenetic liver disorders and acute liver disorders

Country Status (24)

Country Link
US (1) US5863901A (cs)
EP (1) EP0797997B1 (cs)
JP (1) JP4185169B2 (cs)
KR (1) KR100453394B1 (cs)
CN (1) CN1164421A (cs)
AT (1) ATE297749T1 (cs)
AU (1) AU1651697A (cs)
BR (1) BR9701455A (cs)
CA (1) CA2200040A1 (cs)
CZ (1) CZ90797A3 (cs)
DE (2) DE19612067A1 (cs)
DK (1) DK0797997T3 (cs)
ES (1) ES2242973T3 (cs)
HR (1) HRP970171A2 (cs)
HU (1) HUP9700642A3 (cs)
ID (1) ID16413A (cs)
IL (1) IL120521A0 (cs)
NO (1) NO971453L (cs)
PL (1) PL319193A1 (cs)
PT (1) PT797997E (cs)
SI (1) SI0797997T1 (cs)
SK (1) SK39297A3 (cs)
TR (1) TR199700228A2 (cs)
ZA (1) ZA972599B (cs)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1914236A1 (en) 2002-04-10 2008-04-23 Ortho-McNeil Pharmaceutical, Inc. Novel heteroaryl alkylamide derivatives useful as bradykinin receptor modulators
TWI407960B (zh) 2007-03-23 2013-09-11 Jerini Ag 小分子緩激肽ｂ２受體調節劑
CN102159211A (zh) * 2008-06-20 2011-08-17 金尼医疗公司 用于治疗纤维化疾病或病症的组合物
IL274883B2 (en) 2017-11-24 2023-11-01 Pharvaris Netherlands B V BRADYKININ B2 receptor antagonists
AR118982A1 (es) 2019-05-23 2021-11-17 Pharvaris Gmbh Antagonistas cíclicos del receptor b2 de bradiquinina
UY38707A (es) 2019-05-23 2020-12-31 Pharvaris Gmbh Nuevos antagonistas cíclicos del receptor b2 de bradiquinina

Family Cites Families (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4350704A (en) * 1980-10-06 1982-09-21 Warner-Lambert Company Substituted acyl derivatives of octahydro-1H-indole-2-carboxylic acids
US4344949A (en) * 1980-10-03 1982-08-17 Warner-Lambert Company Substituted acyl derivatives of 1,2,3,4-tetrahydroisoquinoline-3-carboxylic acids
US4374847A (en) * 1980-10-27 1983-02-22 Ciba-Geigy Corporation 1-Carboxyalkanoylindoline-2-carboxylic acids
US4693993A (en) * 1985-06-13 1987-09-15 Stewart John M Bradykinin antagonist peptides
US4923963A (en) * 1987-09-02 1990-05-08 Nova Technology Limited Partnership Bradykinin antagonist peptides
AU3428089A (en) * 1988-03-25 1989-10-16 The Administrators Of The Tulane Eductional Fund Therapeutic peptides
DE3926822A1 (de) * 1989-08-14 1991-02-21 Hoechst Ag Peptide mit bradykinin-antagonistischer wirkung
IE63490B1 (en) * 1988-11-24 1995-05-03 Hoechst Ag Peptides having bradykinin antagonist action
DE4013270A1 (de) * 1990-04-26 1991-10-31 Hoechst Ag Peptide mit bradykinin-antagonistischer wirkung
DE69012142D1 (de) * 1989-12-08 1994-10-06 Univ Boston Acylierte bradykininantagonisten und deren verwendung.
MX9100717A (es) * 1990-08-24 1992-04-01 Syntex Inc Antagonistas de la bradiquinina
CZ203693A3 (en) * 1991-04-01 1994-07-13 Cortech Bradykinin antagonists
WO1992018156A1 (en) * 1991-04-19 1992-10-29 Nova Technology Limited Partnership Bradykinin antagonist peptides
ES2123556T3 (es) * 1991-04-19 1999-01-16 Scios Nova Inc Peptidos de tipo bradiquinina.
WO1993011789A1 (en) * 1991-12-12 1993-06-24 Scios Nova Inc. Modified position (7) bradykinin antagonist peptides
FR2686343B1 (fr) * 1992-01-17 1994-03-11 Adir Cie Nouveaux derives pseudopeptidiques a activite antagoniste de la bradykinine, leur procede de preparation et les compositions pharmaceutiques qui les contiennent.
TW258739B (cs) * 1992-04-04 1995-10-01 Hoechst Ag
FR2692581B1 (fr) * 1992-06-18 1994-08-19 Adir Nouveaux dérivés peptidiques à activité antagoniste de la bradykinine, leur procédé de préparation et les compositions pharmaceutiques qui les contiennent.
AU5098593A (en) * 1992-09-11 1994-04-12 Lajos Gera Bradykinin antagonists containing aliphatic amino acids in the 5-position
US5521158A (en) * 1992-10-08 1996-05-28 Scios Nova Inc. Pseudopeptide bradykinin receptor antagonists
IL107400A0 (en) * 1992-11-10 1994-01-25 Cortech Inc Bradykinin antagonists
WO1994019372A1 (en) * 1993-02-17 1994-09-01 Scios Nova Inc. Cyclic bradykinin antagonist peptides
AU680870B2 (en) * 1993-04-28 1997-08-14 Astellas Pharma Inc. New heterocyclic compounds
CA2171446C (en) * 1993-09-09 2004-11-23 Donald James Kyle Pseudo- and non-peptide bradykinin receptor antagonists
DE4345062A1 (de) * 1993-12-31 1995-07-13 Hoechst Ag Verwendung von Bradykinin-Antagonisten zur Herstellung von Arzneimitteln zur Behandlung von Viruserkrankungen
CA2184824A1 (en) * 1994-03-09 1995-09-14 Val S. Goodfellow Bradykinin antagonist peptides incorporating n-substituted glycines

Also Published As

Publication number Publication date
KR100453394B1 (ko) 2004-12-30
PL319193A1 (en) 1997-09-29
JPH1017491A (ja) 1998-01-20
CZ90797A3 (en) 1997-10-15
NO971453D0 (no) 1997-03-26
HRP970171A2 (en) 1998-04-30
PT797997E (pt) 2005-09-30
MX9702292A (es) 1997-09-30
BR9701455A (pt) 1998-08-18
ATE297749T1 (de) 2005-07-15
KR970064622A (ko) 1997-10-13
EP0797997A3 (de) 2000-05-31
DE59712344D1 (de) 2005-07-21
EP0797997A2 (de) 1997-10-01
ZA972599B (en) 1997-09-29
DE19612067A1 (de) 1997-10-02
TR199700228A2 (xx) 1997-10-21
NO971453L (no) 1997-09-29
ES2242973T3 (es) 2005-11-16
SI0797997T1 (en) 2005-10-31
CN1164421A (zh) 1997-11-12
SK39297A3 (en) 1997-10-08
HUP9700642A3 (en) 1998-03-02
HUP9700642A2 (hu) 1998-01-28
CA2200040A1 (en) 1997-09-27
US5863901A (en) 1999-01-26
AU1651697A (en) 1997-10-02
DK0797997T3 (da) 2005-10-17
ID16413A (id) 1997-09-25
HU9700642D0 (en) 1997-05-28
JP4185169B2 (ja) 2008-11-26
EP0797997B1 (de) 2005-06-15

Similar Documents

Publication Publication Date Title
HUP0000558A3 (en) Use of active d vitamin analogues for producing pharmaceutical composition for the treatment of prostatic diseases
ZA975323B (en) Use of strontium salts for the production of pharmaceutical compositions intended for the treatment of arthrosis.
BG102733A (en) New substituted cyclic amino acids as pharmaceutical forms
CA2260145A1 (en) Use of l-acetylcarnitine, l-isovalerylcarnitine, l-propionylcarnitine for increasing the levels of igf-1
CA2301057A1 (en) A method of administering liposomal encapsulated taxane
AU3632497A (en) Use of the chelating agent clioquinol for the manufacture of a pharmaceutical composition for the treatment of alzheimer's disease
HUP9700603A3 (en) Pharmaceutical preparation for the treatment of blood coagulation disorders
WO1998025930A3 (en) Use of bi- and tricyclic pyridone derivatives against alzheimer's disease
PL323798A1 (en) Application of derivatives of vitamin d4 in treating skin diseases
WO1999040883A3 (en) Compositions and methods for the treatment of cystic fibrosis
CA2344407A1 (en) Method for the treatment of mania and bipolar disorder
CA2266608A1 (en) Combination composition in the form of nutritional supplement or pharmaceutical composition for the prevention and therapeutical treatment of degenerative or inflammatory articular disorders
NO975234L (no) Fremgangsmåte for behandling av maniske og bipolare forstyrrelser
ZA972599B (en) Use of bradykinin antagonists for the production of pharmaceuticals for the treatment of chronic fibrogenetic liver disorders and acute liver disorders.
IL134263A0 (en) Use of phanquinone for the treatment of alzheimer's disease
MY121604A (en) Combination therapy for hiv infection using the hiv protease inhibitor indinavir and the reverse transcriptase inhibitor 3tc together with azt
CA2260863A1 (en) Treatment of psychotic disorders
ES2190499T3 (es) Uso de antagonistas de bradiquinina para la preparacion de medicamentos para el tratamiento y la prevencion de la enfermedad de alzheimer.
WO1990006116A3 (de) Mittel zur behandlung von chronisch entzündlichen darmerkrankungen
HUT71422A (en) Use of bradykinin-antagonists for producing pharmaceutical compositions for treating virus diseases
AU4016189A (en) Use of 2-azabicyclo(2.2.2) octane-3-carboxylic acid derivatives for the production of medicinal products intended for the treatment of diseases resulting from impairment of the vascular wall as well as for disorders of the microcirculation
AU5768298A (en) Use of benzoylalkyl-1,2,3,6-tetrahydropyridins
GC0000176A (en) Pharmaceutical combination preparations for the treatment of cardiac disorders
ZA921101B (en) Use of tetra: Hydro-thieno-pyrido-indole derivatives for the prepartion of a medicine for the treatment of skin disorders.
CA2153570A1 (en) Pharmaceutical composition for treating nicotine dependence